DosEmi Study Protocol: a Phase IV, Multicentre, Open-Label, Crossover Study to Evaluate Non-Inferiority of Pharmacokinetic-Guided Reduced Dosing Compared with Conventional Dosing of Emicizumab in People with Haemophilia A
BMJ Open（2023）
关键词
bleeding disorders & coagulopathies,epidemiologic studies,paediatrics,clinical pharmacology,clinical trials
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要